BioSpace News Archive

The agreement to target $108 million for Inspira Technologies over a 7-year period, subject to regulatory approvals.

Continuous studies have been made on the pathophysiology of hyperphosphatemia, evaluation of therapies on the clinical outcomes, and guidelines have shaped the evidence underlying current and emerging treatment options.

The healthcare ERP consulting services market has been anticipated to grow at a noticeable pace during the forecast period.

The COVID-19 pandemic resulted in a positive demand shock for products in the global injectable cytotoxic drugs market.

Fact.MR – A Market Research and Competitive Intelligence Provider: Sales in the global plasma fractionation market are slated to increase at a 7% CAGR, reaching US$ 38 Bn by 2031, as per Fact.MR.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global coronary microcatheters market is forecast to total US$ 363 Mn by 2031, finds Fact.MR in a recent market study.

The women’s health app market is estimated to observe exponential growth during the forecast period of 2021-2031.

Proximie has teamed up with Jhpiego, a Johns Hopkins University affiliate, on a safe surgery project in Kenya to layer in their unique software that allows physicians anywhere in the world to virtually “scrub-in” and mentor colleagues in real time.

HiberCell, a clinical-stage biotechnology company developing therapeutics to address therapeutic resistance, cancer relapse and metastasis, will deliver a virtual presentation on the clinical applications of our odetiglucan therapy for patients with metastatic and late-stage cancer at the ESMO Immuno-Oncology Virtual Congress 2021, December 8-11, 2021.

Dr. Reddy’s Laboratories Ltd. announced the launch of Valsartan Tablets, USP, a therapeutic equivalent generic version of Diovan® Tablets approved by the U.S. Food and Drug Administration.